Paula J Busse MD

Allergy & Immunology•New York, NY

Assistant Professor, Medicine, Icahn School of Medicine

Join to View Full Profile

5 E 98th StNew York, NY 10029
Phone+1 212-241-0764
Fax+1 212-534-0971

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 1999 - 2001
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
University of Rochester School of Medicine and DentistryClass of 1996

Certifications & Licensure

NY State Medical License 1997 - 2026
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants Start of enrollment: 2014 May 14
Completed
Phase 1
Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults
No longer available
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents Start of enrollment: 2022 May 04
RECRUITING
PHASE2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE.
Raffi Tachdjian, Aleena Banerji, Paula J Busse, Nancy Agmon-Levin, John Anderson
Pediatric Allergy and Immunology. 2025-04-01
The relationship between depressive symptoms and coping style on asthma outcomes in older adults.
Naomi Greenfield, Matthew Wysocki, Kimberly Arcoleo, Juliana Rodriguez, Sunit Jariwala
Journal of Behavioral Medicine. 2025-04-01
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting Obstacles.
Sandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, Paula J Busse, Timothy Craig
The Journal of Allergy and Clinical Immunology. in Practice. 2025-03-07

Journal Articles

Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks
Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA

Press Mentions

KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual MeetingMarch 3rd, 2025
Interim Phase 4 Data Support TAKHZYRO® (Lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema PatientsFebruary 28th, 2022
$70m from NIAID to Establish Trial Site Network Focusing on Childhood Asthma in Low-Income Urban CommunitiesApril 26th, 2021
Join now to see all

Grant Support

Childhood Asthma in Urban SettingsICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2028
Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2010
C1 Esterase Inhibitor As Treatment And Prevention In Hereditary AngioedemaNational Center For Research Resources2009
Contribution Of Tnf-Alpha To Mucus Cell Production In AsthmaNational Institute Of Allergy And Infectious Diseases2006–2009
Change TrialNational Center For Research Resources2008
Efficacy And Safety Of Purified C1 Esterase Inhibitor For Treatment Of HaeNational Center For Research Resources2006–2007
An Ascending Four-Dose Placebo Controlled Study To Assess The Efficacy And To...National Center For Research Resources2004

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow